7.1 Topical ophthalmic medications & drug classes

Key Takeaways

  • AAO cap colors are a voluntary guide. Yellow denotes beta-blockers, dark blue their combinations, pink steroids, and gray NSAIDs. Verify every drug and concentration on its label.

  • Glaucoma drops lower IOP by decreasing aqueous production (beta-blockers, alpha-agonists, CAIs) or increasing outflow (prostaglandins, cholinergics).

  • Use the ordered amount. Excess fluid can spill out or drain into the nose and increase systemic exposure.

  • Punctal occlusion after instillation blocks nasolacrimal drainage, keeping the drug on the eye and reducing systemic side effects such as timolol-induced bradycardia.

  • Prolonged or unsupervised use of topical anesthetics can injure the cornea. Follow the clinician’s protocol.

Last updated: November 2026

Topical Ophthalmic Medications and Drug Classes

Topical medications are the backbone of eye care, and the certified ophthalmic technician must understand what each drug class does, why it is prescribed, and how it is instilled. Most ophthalmic drugs are delivered as drops or ointments applied directly to the ocular surface, where the tear film and cornea act as gatekeepers for absorption. A working knowledge of drug classes lets the technician anticipate physician orders, reinforce patient education, and recognize dangerous interactions.

Glaucoma medications

Glaucoma therapy lowers intraocular pressure (IOP) either by decreasing aqueous production or by increasing aqueous outflow.

  • Prostaglandin analogs (latanoprost, bimatoprost, travoprost) increase uveoscleral outflow. They are commonly used to lower IOP. Latanoprost is labeled once daily in the evening. Turquoise is the recommended cap color for this class. Side effects include iris and periocular hyperpigmentation and eyelash growth.
  • Beta-blockers (timolol, betaxolol) reduce aqueous production; yellow is recommended for beta-blockers and dark blue for their combinations. Because they are absorbed systemically, they can cause bradycardia and bronchospasm, so always ask about asthma, COPD, and heart block.
  • Alpha-2 agonists (brimonidine, apraclonidine) both reduce production and increase outflow; caps are purple.
  • Carbonic anhydrase inhibitors (CAIs) (dorzolamide, brinzolamide) decrease production; caps are orange. Oral acetazolamide is the systemic form.
  • Cholinergic (miotic) agents (pilocarpine) increase trabecular outflow and constrict the pupil; caps are dark green.

Diagnostic and surgical agents

  • Mydriatics and cycloplegics dilate the pupil (and, for cycloplegics, relax accommodation) so the physician can examine the fundus. The recommended cap color is red. Verify the name and strength from the label.
  • Topical anesthetics (proparacaine, tetracaine) numb the cornea for tonometry, foreign-body removal, and gonioscopy. Onset is 15-20 seconds and duration 10-20 minutes. Prolonged or unsupervised use can damage the cornea. Use only as authorized under the clinician’s protocol.
  • Vital dyes, chiefly sodium fluorescein, stain areas of epithelial defect and are essential for applanation tonometry and Seidel testing. Fluorescein fluoresces green under cobalt-blue light and can permanently stain soft contact lenses, so lenses are removed first.

Therapeutic drops

  • Antibiotics (fluoroquinolones, aminoglycosides, polymyxin combinations) treat bacterial conjunctivitis and keratitis and provide surgical prophylaxis; caps are tan/brown.
  • Corticosteroids (prednisolone, dexamethasone, loteprednol) suppress inflammation after surgery or uveitis; caps are pink. Steroids raise IOP in responders and can worsen herpetic or fungal infection, so they demand physician oversight.
  • NSAIDs (ketorolac, nepafenac, bromfenac) control pain and cystoid macular edema without the IOP risk of steroids.
  • Artificial tears and lubricants relieve dry eye; preservative-free formulations are preferred for frequent dosing.

Quick-reference: class, action, example, cap color

Drug classActionExampleCap color
Prostaglandin analogIncreases uveoscleral outflowLatanoprostTeal
Beta-blockerDecreases aqueous productionTimololYellow
Alpha-2 agonistDecreases production, increases outflowBrimonidinePurple
Carbonic anhydrase inhibitorDecreases aqueous productionDorzolamideOrange
Cholinergic (miotic)Increases trabecular outflowPilocarpineDark green
Mydriatic/cycloplegicDilates pupil, relaxes accommodationTropicamideRed
AnestheticNumbs corneaProparacaineVerify label
AntibioticKills bacteriaMoxifloxacinTan
SteroidSuppresses inflammationPrednisolonePink
NSAIDReduces prostaglandin synthesisKetorolacGray

Instillation technique and systemic absorption

Correct technique maximizes the dose reaching the eye and minimizes side effects:

  1. Verify the correct patient, drug, eye (right, left, or both), and concentration.
  2. Wash hands and avoid touching the dropper tip to the eye or lashes.
  3. Have the patient tilt the head back and look up; gently pull down the lower lid to form a pocket in the inferior fornix.
  4. Instill the prescribed amount. A single drop is usual. Excess can spill or drain through the nasolacrimal system.
  5. Have the patient close the eyes gently for one to two minutes.
  6. Apply punctal occlusion, light pressure over the lacrimal sac at the inner canthus, to block nasolacrimal drainage. This keeps the drug on the eye and reduces absorption through the vascular nasal mucosa, the main route of systemic side effects such as timolol-induced bradycardia.

Follow each product’s interval instructions to limit washout. For example, the latanoprost label specifies at least five minutes between topical drugs. Aqueous drops generally go before ointment. Teach patients that brief stinging is normal and that suspensions like brinzolamide must be shaken before use for an accurate dose.

Drops, ointments, and combination products

Ointments and gels last longer on the eye and are useful at bedtime or for young children who blink drops away, but they blur vision, so they are usually reserved for nighttime dosing. When both a drop and an ointment are ordered, the drop goes first because an ointment would form a barrier that blocks absorption of a later drop. Combination products simplify regimens and improve adherence: fixed-combination glaucoma drops (for example, a beta-blocker paired with a CAI or an alpha-agonist) deliver two IOP-lowering mechanisms in one bottle, and antibiotic-steroid drops treat infection and inflammation together after certain procedures.

Storage, preservatives, and safety checks

Check each label for the active drug, strength, expiration, storage after opening and discard date. Preservatives may irritate the ocular surface, so flag symptoms or adherence issues for the prescriber. Report a relevant allergy or contraindication before instillation.

Test Your Knowledge

Which glaucoma drug class lowers IOP primarily by increasing uveoscleral outflow and is typically dosed once at night?

A

Prostaglandin analogs

B

Beta-blockers

C

Carbonic anhydrase inhibitors

D

Alpha-2 agonists

Test Your Knowledge

A technician applies gentle pressure over the inner canthus for two minutes after instilling timolol. What is the purpose of this punctal occlusion?

A

To speed the drug's onset of action

B

To reduce stinging on the corneal surface

C

To limit nasolacrimal drainage and systemic absorption

D

To dilate the pupil for examination

Test Your Knowledge

Why is prolonged unsupervised use of a topical ophthalmic anesthetic such as proparacaine unsafe?

A

They are too expensive for outpatient use

B

They permanently stain soft contact lenses

C

They significantly raise intraocular pressure

D

Repeated use is toxic to the corneal epithelium

Sections you finish are checked off in the contents.